Please Wait a Moment
X

Articles

14Feb

CTS to Implement Donor HLA testing on the Stratec Gemini Instrument

14 Feb, 2019 | Return|

On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation. 

Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.

 

 

 

 

Related

Reminder- CTS Form Revisions Implement on September 2, 2019

Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...

Read More >

Update on the Ortho Conversion

At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...

Read More >

Sample submission during the national blood shortage

Through communications with our clients, CTS is aware of the current national blood shortage. We rea...

Read More >

FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma

On December 28, 2021, the FDA updated the emergency use authorization  (EUA) for COVID-19 conva...

Read More >

Assay History List

We have now added a new section called the "Assay History List" to the "At A Gla...

Read More >

Upcoming HCV Testing Algorithm Change

FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...

Read More >